Anthony P. Zook bought $149k of NEO
Chief Executive Officer at NEOGENOMICS INC. 18,900 shares at an average of $7.88, traded May 6, 2025, filed May 8, 2025.
Score components
- +25RoleCEO
- +11Trade size$149k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- +8Price context59% below the 52-week high
- +15Cluster7 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001077183-25-000096, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 6, 2025 | POpen-market purchase Common Stockindirect: Amended and Restated Anthony P. Zook Living Trust | +18,900 | $7.88 | $149k | 18,900 | May 8, 2025 |
Related signals
Other insiders at NEOGENOMICS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 61Notable | NEOGENOMICS INC | Anthony P. Zook Chief Executive Officer | $100k 17,900 shares | +89% | |
| 51Moderate | NEOGENOMICS INC | Jeffrey Scott Sherman Chief Financial Officer | $112k 20,000 shares | +12% | |
| 37Weak | NEObuy NEOGENOMICS INC | Michael Aaron Kelly director | $38k 5,000 shares | - | |
| 53Moderate | NEOGENOMICS INC | Warren Stone Pres & Chief Operating Officer | $49k 5,700 shares | +6% | |
| 46Moderate | NEOGENOMICS INC | Stephen M Kanovsky director | $31k 4,000 shares | +11% | |
| 53Moderate | NEOGENOMICS INC | Lynn A. Tetrault director | $57k 7,000 shares | - | |
| 50Moderate | NEOGENOMICS INC | Neil Gunn director | $35k 4,510 shares | +40% | |
| 54Moderate | NEOGENOMICS INC | David Brian Perez director | $76k 10,000 shares | - | |
| 59Moderate | NEOGENOMICS INC | Jeffrey Scott Sherman Chief Financial Officer | $150k 20,000 shares | +14% | |
| 9Weak | NEOGENOMICS INC | Alicia C Olivo General Counsel | $79k 5,175 shares | -12% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.